| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6064401 | Journal of Allergy and Clinical Immunology | 2014 | 9 Pages |
Abstract
IL-23 inhibition with a single dose of guselkumab results in clinical responses in patients with moderate-to-severe psoriasis, suggesting that neutralization of IL-23 alone is a promising therapy for psoriasis.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Howard MD, Stacy MD, Robert T. MD, Craig L. MD, Cesar PhD, Carrie PhD, Katherine MS, Kim PhD, Stanley J. MBA, Yasmine MD, PhD, Yuhua PhD, Philippe MD, James G. MD, PhD,